Your session is about to expire
← Back to Search
Neurostimulation Device
Nalu SCS System for Chronic Pain (nPower™-US Trial)
N/A
Waitlist Available
Research Sponsored by Nalu Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Summary
This trial tests a small device that sends electrical signals to reduce chronic leg and back pain in adults who still have pain after back surgery. The device works by changing how pain signals are sent to the brain. This method has been shown to be effective in reducing leg and back pain, especially in patients who have not found relief from previous back surgeries.
Eligible Conditions
- Chronic Pain
- Back Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Responders at 3-months
Trial Design
1Treatment groups
Experimental Treatment
Group I: Nalu SCS SystemExperimental Treatment1 Intervention
All eligible subjects will receive the Nalu Neurostimulation System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nalu Neurostimulation System
2020
N/A
~110
Find a Location
Who is running the clinical trial?
Nalu Medical, Inc.Lead Sponsor
2 Previous Clinical Trials
250 Total Patients Enrolled
2 Trials studying Chronic Pain
250 Patients Enrolled for Chronic Pain
JIm Makous, PhDStudy DirectorNalu Medical, Inc.
Patrick MartinStudy DirectorNalu Medical
2 Previous Clinical Trials
250 Total Patients Enrolled
2 Trials studying Chronic Pain
250 Patients Enrolled for Chronic Pain
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger